Search

Three liver hazards, two confirmed—hepatitis B virus (HBV) and aflatoxin (AFB), and one rarely studied in populations—microcystin (MC), simultaneously exist in tropical and humid areas; however, there are no epidemiological data on their risks in the same population. We conducted a community-based cross-sectional survey among 5493 adults in two rural towns and statistically analyzed the comparative and combinative effects of the three factors after detecting HBsAg and HBV DNA titers, determining estimated daily intakes (EDIs) of AFB1 and MC-LR and testing serum AST and ALT as liver injury markers for each participant. We observed a HBsAg(+) rate of 7.6%, a relatively high AFB1 exposure level (mean EDIAFB1 = 471.30 ng/d), and a relatively low MC-LR exposure level (mean EDIMC-LR = 228.25 ng/d). ORs for abnormal AST (2.42, 95%CI = 1.69–3.45) and ALT (2.87, 95%CI = 1.91–4.29) increased in HBV infections compared with HBV-unexposed participants but did not increase in participants with separate or combined exp...

Although the nephrotoxicity of microcystin and aflatoxin has been observed in animal and clinical cases, few population data are available. We conducted a cross-sectional study in Southwest China to investigate the association of renal function indicators (RFIs, including BUN, SCr, and eGFR) with exposure to microcystin and aflatoxin in 5493 members of the general population. Microcystin-LR levels in water and aquatic products and aflatoxin B1 levels in daily foods were measured by ELISA, and individual estimated daily intake (EDI) was assessed on the basis of the measurement and questionnaire. We found that participants with abnormal RFIs had a much higher mean level of microcystin-LR EDI than those with normal RFIs and that there was a significant increasing trend for abnormal rates and odds ratios of RFIs with increasing microcystin-LR EDI quartiles (p for trend = 0.000). Compared with the lowest quartile of microcystin-LR exposure, those in the highest quartile had significantly higher risks of abnormal BUN (OR = 1.80, 95% CI = 1.34-2.42), SCr (OR = 4.58, 95% CI = 2.92-7.21), and eGFR (OR = 4.41, 95% CI = 2.55-7.63), respectively, but no higher risk was found in subjects with higher AFB1 exposure. After adjustment for confounding factors, risk associations with microcystin-LR persisted. Consequently, our results suggest that microcystin, rather than aflatoxin, might be one important risk of renal-function impairment.

The important d -glucose and d -glucose 6-phosphate analogues 1,5-anhydro- d -glucitol and 1,5-anhydro- d -glucitol 6-phosphate were prepared from methyl- d -glucoside in high yield and purity. Protecting of the hydroxyl groups as their allyl ether followed by reductive cleavage of the glycosidic linkage with triethylsilane formed the protected anhydroglucitol. No ring rearrangement or ring contraction was observed during the reduction step. Using the PdCl 2 –CuCl 2 –activated charcoal system, the allyl ether bond was cleaved with a low loading of the catalyst (0.0025 equiv per allyl group). 1,5-Anhydro- d -glucitol 6-phosphate was prepared by the phosphylation of 1,5-anhydro- d -glucitol.

Cage-like octa(trimethylsiloxy)silsesquioxane [ (Me3SiO)SiO1.5]8 has been synthesized via the trimethylsilylation of cubic tetramethylammonium silicate octamer [(Me4NO)-SiO1.5]8 with chlorotrimethylsilane. The silicate octamer can be selectively formed by the reaction of tetraethoxysilane Si(OEt)4 with aqueous tetramethylammonium hydroxide in equal molar ratio. Elementary analysis, FT-IR,1H,13C,29Si NMR are used to characterize these silsesquioxanes.

A facile three-step sequence for the preparation of anhydroalditols starting from commodity carbohydrates is presented.